Oral DNA               Your Mouth, Your Body, Your Health  
 
     
 
Home Professionals Patients Who we are Our Tests Resource Center Contact Us
 
 
Management
News and Events
Courses
Technical Updates

Innovative salivary diagnostic tests from OralDNA® Labs are fundamental elements of a patient's wellness plan:

MyPerioPath® - Determines the cause of periodontal infections

In Depth: Identifies the type and concentration of specific perio-pathogenic bacteria that are known to cause periodontal disease. MyPerioPath® helps support the clinician with better risk assessment and personalized treatment options for more predictable patient outcomes.

Patient Profiles:

  • Patients presenting with signs and symptoms of a periodontal infection
  • Patients with pockets of 4mm or greater with clinical signs of a periodontal infection
  • Patients presenting chronic periodontal disease who is not responding positively to
    their current treatment
  • Patients with Type I or Type II diabetes
  • Patients with a history of Cardiovascular disease
  • Patients who use tobacco products
  • Patients that will undergo surgical procedures or radiation treatment
  • Can be used as a "Baseline" for any patient that may be at increased risk for
    periodontal infections
  • Patients who test positive for genetic susceptibility with the MyPerioID® PST® test
  • Women of child bearing age


Click to view sample MyPerioPath® report

MyPerioID® PST® - Determines who is at increased risk for severe periodontal infections

In Depth: Identifies individual genetic susceptibility to periodontal disease and enables the clinician to establish which patients are at increased risk for more severe periodontal infections due to an exaggerated immune response.

Patient Profiles:

  • Patients with a family history of periodontal disease
  • Patients with compromised immune systems
  • Patients that have received therapy but continue with disease activity
  • Patients that will receive implants and have lost teeth to periodontal disease
  • Adolescent patients


Click to view a sample MyPeriodID® PST ® report

OraRisksm HPV - Determines who is at increased risk for HPV-related oral cancers

In Depth: A non-invasive, easy-to-use screening tool to identify the type(s) of HPV, a mucosal viral infection that could potentially lead to oral cancer. OraRisksm HPV enables the clinician to establish increased risk for oral cancer and determine appropriate referral and monitoring conditions.

Patient Profiles:

  • Patients who are sexually active
  • Patients with signs and symptoms of oral cancer
  • Patients with traditional risk factors for oral cancer
  • Patients with suspicious oral lesions


Click to view a sample OraRisksm HPV report

* PST is a registered trademark of Interleukin Genetics

 
 

214 Overlook Circle / Suite 120 / Brentwood, TN 37027 / Phone: 877.577.9055
CLIA: 44D1087138 - 2010 OralDNA® Labs All rights reserved.